Mazzolai L, Nussberger J, Aubert J F, Brunner D B, Gabbiani G, Brunner H R, Pedrazzini T
Division of Hypertension and Vascular Medicine, University of Lausanne Medical School, Switzerland.
Hypertension. 1998 Jun;31(6):1324-30. doi: 10.1161/01.hyp.31.6.1324.
Cardiac hypertrophy is frequent in chronic hypertension. The renin-angiotensin system, via its effector angiotensin II (Ang II), regulates blood pressure and participates in sustaining hypertension. In addition, a growing body of evidence indicates that Ang II acts also as a growth factor. However, it is still a matter of debate whether the trophic effect of Ang II can trigger cardiac hypertrophy in the absence of elevated blood pressure. To address this question, transgenic mice overexpressing the rat angiotensinogen gene, specifically in the heart, were generated to increase the local activity of the renin-angiotensin system and therefore Ang II production. These mice develop myocardial hypertrophy without signs of fibrosis independently from the presence of hypertension, demonstrating that local Ang II production is important in mediating the hypertrophic response in vivo.
心脏肥大在慢性高血压中很常见。肾素-血管紧张素系统通过其效应分子血管紧张素II(Ang II)调节血压并参与维持高血压。此外,越来越多的证据表明Ang II还作为一种生长因子发挥作用。然而,在血压未升高的情况下,Ang II的营养作用是否能引发心脏肥大仍存在争议。为了解决这个问题,构建了在心脏中特异性过表达大鼠血管紧张素原基因的转基因小鼠,以增加肾素-血管紧张素系统的局部活性,从而增加Ang II的产生。这些小鼠在无高血压的情况下出现心肌肥大且无纤维化迹象,表明局部Ang II的产生在介导体内肥大反应中很重要。